Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 29 Jan 2024
Benefit from immune checkpoint inhibitor more than doubles when compared to observation.
Read Full NewsClosing the COVID-19 Prevention Gap This Flu Season, With Juanita Mora, MD
Darren Gitelman, MD, senior medical director of the Advocate Memory Center in Park Ridge, discusses findings linking high-dose influenza vaccination to lower Alzheimer disease risk, study limitations, and potential implications for future dementia prevention research.
Postmarketing reports of product-related insertional oncogenesis involving GLI1 have prompted an FDA investigation into malignancy risk with SMA gene therapy, onasemnogene abeparvovec.
1.
Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.
2.
An Eye Surgeon's Unexpected Discovery of the "Before and After".
3.
FDA approves Blenrep for relapsed or refractory multiple myeloma
4.
Many Americans unaware of links between HPV and cancers, poll reveals
5.
Investigations may result in novel combination therapies for early-stage lung cancers.
1.
Cancer Rates on the Rise: What Can We Do to Stop It?
2.
Mechanisms of Tumor–Stromal Communication During Cancer Progression
3.
Strategic Developments in Hematology and Quality Improvement
4.
Age-Related Changes in Red Cell Membrane Protein Organization
5.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Diagnosis and Management in Hematology
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge